JP2024516115A5 - - Google Patents

Info

Publication number
JP2024516115A5
JP2024516115A5 JP2023562250A JP2023562250A JP2024516115A5 JP 2024516115 A5 JP2024516115 A5 JP 2024516115A5 JP 2023562250 A JP2023562250 A JP 2023562250A JP 2023562250 A JP2023562250 A JP 2023562250A JP 2024516115 A5 JP2024516115 A5 JP 2024516115A5
Authority
JP
Japan
Prior art keywords
hepatitis
prevention
treatment
virus infection
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023562250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516115A (ja
Filing date
Publication date
Priority claimed from CN202110374234.2A external-priority patent/CN114107393A/zh
Application filed filed Critical
Publication of JP2024516115A publication Critical patent/JP2024516115A/ja
Publication of JP2024516115A5 publication Critical patent/JP2024516115A5/ja
Pending legal-status Critical Current

Links

JP2023562250A 2021-04-07 2022-04-07 レンチウイルスベクター、ｂ型肝炎を処置する為のレンチウイルス粒子、並びにその調製方法及びその用途 Pending JP2024516115A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110374234.2 2021-04-07
CN202110374234.2A CN114107393A (zh) 2021-04-07 2021-04-07 一种治疗乙型肝炎的慢病毒载体、慢病毒颗粒及其制备方法和应用
PCT/EP2022/059281 WO2022214599A1 (en) 2021-04-07 2022-04-07 Lentiviral vector, lentiviral particle for treating hepatitis b and its preparation method and application thereof

Publications (2)

Publication Number Publication Date
JP2024516115A JP2024516115A (ja) 2024-04-12
JP2024516115A5 true JP2024516115A5 (https=) 2025-04-02

Family

ID=80359264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023562250A Pending JP2024516115A (ja) 2021-04-07 2022-04-07 レンチウイルスベクター、ｂ型肝炎を処置する為のレンチウイルス粒子、並びにその調製方法及びその用途

Country Status (11)

Country Link
US (1) US20250073332A1 (https=)
EP (1) EP4319805A1 (https=)
JP (1) JP2024516115A (https=)
KR (1) KR20240004429A (https=)
CN (2) CN114107393A (https=)
AU (1) AU2022255056A1 (https=)
BR (1) BR112023020732A2 (https=)
CA (1) CA3214383A1 (https=)
TW (1) TWI906499B (https=)
WO (1) WO2022214599A1 (https=)
ZA (1) ZA202309368B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024159517A1 (zh) * 2023-02-03 2024-08-08 南方科技大学 一种乙型肝炎mRNA及其疫苗与用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081069C (zh) 1998-08-14 2002-03-20 饶纬华 乙型肝炎治疗性疫苗及其制备方法
US8158413B2 (en) 2005-10-17 2012-04-17 Institut Pasteur Lentiviral vector-based vaccine
WO2008103380A2 (en) * 2007-02-21 2008-08-28 Fox Chase Cancer Center Hepatitis b virus compositions and methods of use
DK2185192T3 (en) 2007-08-03 2019-02-18 Pasteur Institut LENTIVIRAL TRANSFER VECTORS AND THEIR MEDICAL USES
CN101502650B (zh) * 2009-03-10 2011-12-28 邢益平 密码子优化的乙型肝炎核酸疫苗
EP2666477A1 (en) 2012-05-23 2013-11-27 Theravectys Lentiviral vectors containing an MHC class I promoter
CA2849652C (en) 2011-09-26 2017-11-21 Theravectys Use of non-subtype b gag proteins for lentiviral packaging
RS61118B1 (sr) * 2016-01-12 2020-12-31 Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh Sredstva i postupci za lečenje hbv
EP3276006A1 (en) * 2016-07-27 2018-01-31 Theravectys Lentiviral vectors for expression of hepatitis b virus (hbv) antigens
EP3532084A4 (en) * 2016-10-31 2020-05-27 Georgia State University Research Foundation, Inc. VIRUS-LIKE HEPATITIS-B-VIRUS-PRÄ-S-PROTEIN PARTICLE
CN106928372B (zh) * 2016-12-30 2019-09-13 北京大学深圳研究生院 乙肝重组抗原及其表达基因、构建方法、病毒样颗粒及其制备方法、应用与疫苗
CN107058346B (zh) * 2017-05-03 2021-01-29 李军涛 一种乙肝病毒表面抗原基因与表达载体及细胞株
CA3132601A1 (en) * 2019-03-05 2020-09-10 Glaxosmithkline Biologicals Sa Hepatitis b immunisation regimen and compositions

Similar Documents

Publication Publication Date Title
Porta et al. The development of cowpea mosaic virus as a potential source of novel vaccines
JP2019527055A5 (https=)
CN1912112A (zh) 重组的感染性不分节段的负链rna病毒
JPH06508153A (ja) 免疫不全ウイルス用の遺伝子ワクチン
BR112014015390B1 (pt) Proteína de matriz modificada (m) de um vírus da estomatite vesicular, vírus da estomatite vesicular recombinante, vacina compreendendo o mesmo, kit e uso de uma vacina
AU588462B2 (en) Non-cytopathic clone of human t-cell lymphotropic virus type iii
CN118750594B (zh) 一种二价猪口蹄疫mRNA疫苗及其制备方法和应用
WO2021207848A1 (en) Mers-cov vaccine
CA2033175C (en) Self-assembled, defective, non-self-propagating viral particles
JPH01500161A (ja) Ａｉｄｓの原因ウィルスの糖蛋白質、該糖蛋白質の製造方法及びワクチン
CN112552413A (zh) 新型冠状病毒重组蛋白亚单位疫苗
JP2024516115A5 (https=)
Hourioux et al. Identification of the Glycoprotein 41™ Cytoplasmic Tail Domains of Human Immunodeficiency Virus Type 1 That Interact with Pr55Gag Particles
JPH05501654A (ja) 霊長類レンチウイルスワクチン
WO1999020650A1 (fr) Peptides issus de gene env du virus de l'immunodeficience feline et leurs applications
CN115197969B (zh) 一种治疗乙型肝炎的慢病毒载体、慢病毒颗粒及其制备方法和应用
WO2021179351A1 (zh) 一种诱导针对hiv-1的广谱中和抗体的免疫组合
CN115990249B (zh) 一种登革四价dna疫苗及其应用
EP0276591B1 (fr) Vaccin constitué par un vecteur viral et ADN recombinant codant notamment pour la protéine p25 du virus agent causal du S.I.D.A.
CN116004725A (zh) 间充质干细胞在疼痛相关疾病中的应用
CA2597878A1 (en) Capsid protein and use therefore
CN1772892A (zh) Hiv－1病毒样颗粒及其制备方法与用途
CN1137896C (zh) 新型口蹄疫疫苗及其制备方法
HK40074915B (zh) 一种治疗乙型肝炎的慢病毒载体、慢病毒颗粒及其制备方法和应用
HK40074915A (en) A kind of lentiviral vector, lentiviral particle for treating hepatitis b and its preparation method and application